Health Trials

Endometrial Cancer Stage III

2

Review clinical trials related to Endometrial Cancer Stage III. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort)

The PURE trial is a prospective multicenter phase II study evaluating the safety and feasibility of ultra-hypofractionated adjuvant pelvic radiotherapy in patients with high-intermediate-risk and high-risk endometrial cancer following surgery. The study investigates a treatment regimen consisting of 27.5 Gy delivered in five fractions using modern image-guided IMRT/VMAT techniques. The primary objective is to assess acute gastrointestinal and genitourinary toxicity according to CTCAE version 5.0.

Participants needed: 50
Trial details
Age: 18-110Biological sex: FemaleType: InterventionalSponsor: Instituto de Investigación Sanitaria AragónUpdated: Aug 21, 2026Locations: 1
Eligibility criteria

Aged > 18 years. [+6]

Prior pelvic or abdominal radiation therapy delivered. [+2]

Read more
Status: Recruiting

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

The PROMOTE study aims at optimising use of hormonal therapy in advanced stage and recurrent endometrial cancer analysing tumor tissue taken before start of hormonal therapy

Participants needed: 150
Trial details
Age: 18-110Biological sex: FemaleType: ObservationalSponsor: Radboud University Medical CenterUpdated: Jan 18, 2023Locations: 1Duration: 2 Years
Eligibility criteria

Advanced stage (FIGO stage III and IV) and recurrent endometrial cancer [+3]

Adjuvant hormonal therapy started following complete resection of endometrial ca... [+2]

Read more